Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cara Therapeutics | CARA | Dec 24, 2024 | 0.46 | +1.36 |
Caravelle International Group | CACO | Dec 24, 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | Dec 24, 2024 | 9.16 | +135.48 |
Cardiff Oncology | CRDF | Dec 24, 2024 | 3.92 | -3.69 |
Cardinal Health | CAH | Dec 24, 2024 | 118.83 | +0.41 |
Cardio Diagnostics | CDIO | Dec 24, 2024 | 1.01 | -1.94 |
Cardiol Therapeutics | CRDL | Dec 24, 2024 | 1.26 | +0.80 |
Cardlytics | CDLX | Dec 24, 2024 | 3.87 | +0.26 |
CareCloud | CCLD | Dec 24, 2024 | 3.95 | +6.76 |
CareCloud A Pref | CCLDP | Dec 24, 2024 | 18.25 | +0.22 |
CareCloud B Pref | CCLDO | Dec 24, 2024 | 18.30 | +1.32 |
CareDx | CDNA | Dec 24, 2024 | 21.42 | +2.34 |
CareMax A | CMAX | Dec 24, 2024 | 0.42 | 0.00 |
CareTrust REIT | CTRE | Dec 24, 2024 | 27.39 | +0.62 |
CARGO Therapeutics | CRGX | Dec 24, 2024 | 14.66 | -0.41 |
CarGurus A | CARG | Dec 24, 2024 | 36.54 | +1.73 |
Caribou Biosciences | CRBU | Dec 24, 2024 | 1.69 | -5.59 |
Carisma Therapeutics | CARM | Dec 24, 2024 | 0.40 | +2.84 |
Carlisle Companies | CSL | Dec 24, 2024 | 376.45 | -0.02 |
Carlyle Credit Income Fund | CCIF | Dec 24, 2024 | 8.06 | +1.00 |
Carlyle Credit Income Fund | CCIA | Dec 24, 2024 | 25.71 | +0.04 |
Carlyle Secured Lending | CGBD | Dec 24, 2024 | 18.04 | +0.95 |
CarMax | KMX | Dec 24, 2024 | 84.91 | +1.45 |
Carmell | CTCX | Dec 24, 2024 | 0.28 | +26.20 |
Carnival | CCL | Dec 24, 2024 | 25.79 | +0.23 |
Carnival ADR | CUK | Dec 24, 2024 | 23.25 | -0.34 |
CarParts.com | PRTS | Dec 24, 2024 | 0.92 | -1.98 |
Carpenter Technology | CRS | Dec 24, 2024 | 174.52 | +1.11 |
Carriage Services | CSV | Dec 24, 2024 | 40.32 | +0.57 |
Carrier Global | CARR | Dec 24, 2024 | 69.45 | +0.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.